Jacqueline Lehmann‐Che

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index5.6kcitations208works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(35), Cancer-related Molecular Pathways(27), Breast Cancer Treatment Studies(26), interferon and immune responses(26), Cancer Mechanisms and Therapy(25)

Publications207 total

Mycosis fungoides with nodal progression harbors recurrent SOCS1 mutations and JAK2 rearrangements
European Journal of Cancer·2025
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases
Neuro-Oncology Practice·2025
SeqOIA platform, an integrative and interactive approach to optimize personalized cancer treatment
2025Open Access
Long‐term follow‐up and combined Phase 2 results of eprenetapopt and azacitidine in patients with <i>TP53</i> mutant MDS/AML
HemaSphere·2025· 4 citedOpen Access
FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Cancers·2025· 7 citedOpen Access
Metabolic Heterogeneity in Diffuse Large B-Cell Lymphoma Cells Reveals an Innovative Antimetabolic Combination Strategy
Cancers·2025Open Access
FDG-PET/CT and multimodal machine learning model prediction of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
2024Open Access
Metabolic heterogeneity in DLBCL cells reveals an innovative antimetabolic combination strategy
2024Open Access
Spatial transcriptomics unveils immune cellular ecosystems associated with patient survival in diffuse large B-cell lymphoma
2024Open Access
768P Reclassification and variant distribution in the GINECO GREAT study of ovarian cancer patients: Insights into HRD status
Annals of Oncology·2024· 1 citedOpen Access
Enhanced expression of galectin‐9 in triple negative breast cancer cells following radiotherapy: Implications for targeted therapy
International Journal of Cancer·2024· 4 citedOpen Access
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review
European Urology Oncology·2024· 3 cited
Sarco/endoplasmic reticulum calcium ATPase 3 (SERCA3) expression in gastrointestinal stromal tumours
Pathology·2023· 3 citedOpen Access
483P Prognostic value of androgen receptor expression in patients with advanced triple-negative metastatic breast cancer treated with sacituzumab govitecan: A French multicentre retrospective study
Annals of Oncology·2023Open Access
Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study)
PLoS ONE·2023· 10 citedOpen Access
Primary cutaneous follicle center lymphoma with secondary systemic evolution
European Journal of Cancer·2023
KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM
Neuro-Oncology·2023· 3 citedOpen Access
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!
Biomedicines·2023· 7 citedOpen Access
Primary cutaneous follicle centre lymphoma with secondary systemic evolution
JEADV Clinical Practice·2023· 1 citedOpen Access
Anti-telomerase vaccine in patients with newly diagnosed, unmethylated MGMT glioblastoma: A phase II study.
Journal of Clinical Oncology·2023· 7 cited
page 1 of 11Next →

Frequent Co-authors

Hugues de Thé(18), Patricia de Crémoux(11), Marc Espié(10), Sylvie Giacchetti(7), Anne de Roquancourt(7), Philippe Bertheau(7), Anne Janin(6), M. Marty(6), Ali Saı̈b(6), Pierre Fenaux(5), Brigitte Poirot(5), Elisabeth Turpin(5), Louis‐François Plassa(5), Christos Sotiriou(5), David Groheux(4), Raphaël Porcher(4), Anne‐Sophie Hamy(4), C. Cuvier(4), Ivan Bièche(4), Mariana Varna(4)